LONZA GROUP UNSP.ADR 1/10 (LO3A) - Total Assets
Based on the latest financial reports, LONZA GROUP UNSP.ADR 1/10 (LO3A) holds total assets worth €17.91 Billion EUR (≈ $20.94 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
LONZA GROUP UNSP.ADR 1/10 - Total Assets Trend (2022–2025)
This chart illustrates how LONZA GROUP UNSP.ADR 1/10's total assets have evolved over time, based on quarterly financial data. Also see market value of LONZA GROUP UNSP.ADR 1/10 for the company's overall valuation and market capitalisation.
LONZA GROUP UNSP.ADR 1/10 - Asset Composition Analysis
Current Asset Composition (December 2025)
LONZA GROUP UNSP.ADR 1/10's total assets of €17.91 Billion consist of 42.2% current assets and 57.8% non-current assets. Review LONZA GROUP UNSP.ADR 1/10 balance sheet liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 3.8% |
| Accounts Receivable | €1.06 Billion | 5.6% |
| Inventory | €1.68 Billion | 8.9% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €329.00 Million | 1.7% |
| Goodwill | €1.96 Billion | 10.3% |
Asset Composition Trend (2022–2025)
This chart illustrates how LONZA GROUP UNSP.ADR 1/10's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See LO3A stock price and chart for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: LONZA GROUP UNSP.ADR 1/10's current assets represent 42.2% of total assets in 2025, an increase from 32.9% in 2022.
- Cash Position: Cash and equivalents constituted 3.8% of total assets in 2025, down from 7.7% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, a decrease from 28.0% in 2022.
- Asset Diversification: The largest asset category is goodwill at 10.3% of total assets.
LONZA GROUP UNSP.ADR 1/10 Competitors by Total Assets
Key competitors of LONZA GROUP UNSP.ADR 1/10 based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
GeneDx Holdings Corp.
NASDAQ:WGS
|
USA | $481.49 Million |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Healius Ltd
AU:HLS
|
Australia | AU$1.77 Billion |
|
Microba Life Sciences Ltd
AU:MAP
|
Australia | AU$43.35 Million |
|
Genetic Signatures Ltd
AU:GSS
|
Australia | AU$49.04 Million |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$510.21 Million |
LONZA GROUP UNSP.ADR 1/10 - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.89 | 1.52 | 2.04 |
| Quick Ratio | 1.42 | 1.04 | 1.38 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €3.21 Billion | €1.86 Billion | €2.72 Billion |
LONZA GROUP UNSP.ADR 1/10 - Advanced Valuation Insights
This section examines the relationship between LONZA GROUP UNSP.ADR 1/10's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.20 |
| Latest Market Cap to Assets Ratio | 2.16 |
| Asset Growth Rate (YoY) | -3.9% |
| Total Assets | €18.97 Billion |
| Market Capitalization | $41.04 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values LONZA GROUP UNSP.ADR 1/10's assets at a significant premium (2.16x), suggesting investors see substantial growth potential or unique competitive advantages.
Slight Asset Contraction: LONZA GROUP UNSP.ADR 1/10's assets decreased by 3.9% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for LONZA GROUP UNSP.ADR 1/10 (2022–2025)
The table below shows the annual total assets of LONZA GROUP UNSP.ADR 1/10 from 2022 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €18.97 Billion ≈ $22.17 Billion |
-3.88% |
| 2024-12-31 | €19.73 Billion ≈ $23.07 Billion |
+17.12% |
| 2023-12-31 | €16.85 Billion ≈ $19.70 Billion |
-2.93% |
| 2022-12-31 | €17.36 Billion ≈ $20.29 Billion |
-- |
About LONZA GROUP UNSP.ADR 1/10
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics; Small Molecules; Cell & Gene; and Capsules & Health Ingredients segments. The Biologics segment engages in the contract develo… Read more